Cite

1. Dall’Era M, Wofsy D. Clinical Manifestations of Systemic Lupus Erythematosus. Firestein GS, Budd RC, Gabriel SE, MacInnes IB, O’Dell JR, eds. Kelley and Firestein’s Textbook of Rheumatology. 10th ed. Philadelphia, Pa: Elsevier Saunders; 2017. 1345-67.10.1016/B978-0-323-31696-5.00080-2Search in Google Scholar

2. Daniel J Wallace, MD, Dafna D Gladman, MD, FRCPC, Clinical manifestations and diagnosis of systemic lupus erythematosus in adults, https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-systemic-lupus-erythematosus-in-adults?search=lupus%20erythematosus&topicRef=4675&source=see_linkSearch in Google Scholar

3. Botou A, Bangeas A, Alexiou I et al. Acroosteolysis. Clin Rheumatol 2017;36:914Search in Google Scholar

4. L. Guillevin, Vasculopathy and pulmonary arterial hypertension, Rheumatology, Volume 48, Issue suppl_3, 1 June 2009, Pages iii54–iii57, https://doi.org/10.1093/rheumatology/ken48410.1093/rheumatology/ken48419487226Search in Google Scholar

5. A.K.ROBSON,* S.M.BURGEt & P.R.MILLARDS, Nasal mucosal involvement in lupus erythematosus. Clin. Otolaryngol. 1992, 17, 341-34310.1111/j.1365-2273.1992.tb01009.x1526055Search in Google Scholar

6. Yayoi Nagai, Akira Shimizu, Mariko Suto, Setsuko Tanaka, Masahito Yasuda, Osamu Tago, Michiko Hasegawa and Osamu Ishika, Digital Gangrene in Systemic Lupus Erythematosus. Acta Derm Venereol 2009; 89: 398–401Search in Google Scholar

7. Paul F Dellaripa, MD, Sonye K Danoff, MD, PhD, Pulmonary manifestations of systemic lupus erythematosus in adults, https://www.uptodate.com/contents/pulmonary-manifestations-of-systemic-lupuserythematosus-in-adultsSearch in Google Scholar

8. Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol. 2016;9:1-9. Published 2016 Dec 20. doi:10.2147/OARRR.S12354910.2147/OARRR.S123549519162328053559Search in Google Scholar

9. Alarcon Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Kasukawa R, Sharp G (Eds), Elsevier, Amsterdam 1987. p.33.Search in Google Scholar

10. Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169-1178. doi:10.1007/s00296-018-4059-410.1007/s00296-018-4059-429796907Search in Google Scholar

11. Rahman P, Gladman DD, Urowitz MB. Nasal-septal perforation in systemic lupus erythematosus — time for a closer look. J Rheumatol 1999;26:1854-5.Search in Google Scholar

12. Bruno E, Russo S, Nucci R, Alessandrini M, DiGirolamo S. Nasal mucosal involvement in systemic lupus erythematosus: histopathologic and immunopathologic study. Int J Immunopathol Pharmacol 2000;13:39-42.10.1177/03946320000130010612749777Search in Google Scholar

13. Guntupalli, L., Patel, K., Faraji, F., & Brunworth, J. D. (2017). Autoimmune-Related Nasal Septum Perforation: A Case Report and Systematic Review. Allergy & Rhinology. https://doi.org/10.2500/ar.2017.8.019110.2500/ar.2017.8.0191538045228381327Search in Google Scholar

14. Willkens RF, Roth GJ, Novak A, Walike JW. Perforation of nasal septum in rheumatic diseases. Arthritis Rheum 1976; 19:119.10.1002/art.17801901221252263Search in Google Scholar

15. Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55:159.10.1136/thorax.55.2.159174567810639536Search in Google Scholar

eISSN:
1220-5818
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Pneumology